(Q34924520)

5 August 2017

title

Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain (English)

1 reference

5 August 2017

0 references

0 references

0 references

0 references

Anna Leichsenring

1

1 reference

5 August 2017

Michael Andriske

2

1 reference

5 August 2017

Ingo Bäcker

3

1 reference

5 August 2017

Christine C Stichel

4

1 reference

5 August 2017

Hermann Lübbert

5

1 reference

5 August 2017

publication date

18 January 2009

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

379

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

627-636

1 reference

Adverse effects of cannabis and cannabinoids

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00210-008-0386-4

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-008-0386-4

Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-008-0386-4

Adverse effects of medical cannabinoids: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-008-0386-4

Cannabinoid receptor localization in brain

21 January 2018

1 reference

12 December 2020

Role of the cysteine protease cathepsin S in neuropathic hyperalgesia

1 reference

12 December 2020

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

1 reference

12 December 2020

Two distinctive antinociceptive systems in rats with pathological pain.

1 reference

12 December 2020

Cannabinoid signaling in glial cells

1 reference

12 December 2020

Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain

1 reference

12 December 2020

Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation

1 reference

12 December 2020

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

1 reference

12 December 2020

Targeting cannabinoid agonists for inflammatory and neuropathic pain

1 reference

12 December 2020

The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

1 reference

12 December 2020

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

1 reference

12 December 2020

Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

1 reference

12 December 2020

Cannabinoids and pain

1 reference

12 December 2020

Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

1 reference

12 December 2020

Pharmacological characterization of the chronic constriction injury model of neuropathic pain

1 reference

12 December 2020

The emerging functions of endocannabinoid signaling during CNS development.

1 reference

12 December 2020

Immune and glial cell factors as pain mediators and modulators

1 reference

12 December 2020

Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.

1 reference

12 December 2020

Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision

1 reference

12 December 2020

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

1 reference

12 December 2020

Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain

1 reference

12 December 2020

Association of neural inflammation with hyperalgesia following spinal nerve ligation.

1 reference

12 December 2020

A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mouse

1 reference

12 December 2020

Presence and functional regulation of cannabinoid receptors in immune cells

1 reference

12 December 2020

Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences.

1 reference

12 December 2020

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study

1 reference

12 December 2020

Pharmacology of cannabinoids

1 reference

12 December 2020

The biochemical origin of pain--proposing a new law of pain: the origin of all pain is inflammation and the inflammatory response. Part 1 of 3--a unifying law of pain

1 reference

12 December 2020

Glia: a novel drug discovery target for clinical pain

1 reference

12 December 2020

Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons

1 reference

12 December 2020

Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats

1 reference

12 December 2020

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

1 reference

12 December 2020

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.

1 reference

12 December 2020

Differential expression of Cathepsin S and X in the spinal cord of a rat neuropathic pain model

1 reference

12 December 2020

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

1 reference

12 December 2020

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833

1 reference

12 December 2020

Lumbar sympathectomy failed to reverse mechanical allodynia- and hyperalgesia-like behavior in rats with L5 spinal nerve injury

1 reference

12 December 2020

Identification and functional characterization of brainstem cannabinoid CB2 receptors

1 reference

12 December 2020

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes

1 reference

12 December 2020

Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain

1 reference

12 December 2020

The effects of cannabinoids on the brain

1 reference

12 December 2020

Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry

1 reference

12 December 2020

Reassessment of the role of cannabinoids in the management of pain

1 reference

12 December 2020

Localization of cannabinoid receptor mRNA in rat brain

1 reference

12 December 2020

In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models

1 reference

12 December 2020

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

1 reference

12 December 2020

Immune and inflammatory mechanisms in neuropathic pain

1 reference

12 December 2020

The endocannabinoid system as an emerging target of pharmacotherapy

1 reference

12 December 2020

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

1 reference

12 December 2020

An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

1 reference

12 December 2020

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

1 reference

12 December 2020

Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids

1 reference

12 December 2020

Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain

1 reference

12 December 2020

10.1007/S00210-008-0386-4

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1036594049

0 references

Fatcat ID

release_tlkbbegaofb6bmj3cpj6jgj4le

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tlkbbegaofb6bmj3cpj6jgj4le

24 November 2022

mapped directly with Wikidata item

1 reference